Bosic-Reiniger Jade, Martin James L, Brown Karen E, Anderson Heather D, Blackburn Hayley, Kao David P, Trinkley Katy E, Woodahl Erica L, Aquilante Christina L
L.S. Skaggs Institute for Health Innovation, University of Montana, Missoula, MT 59812, United States.
Department of Pharmacy Practice, University of Montana, Missoula, MT 59812, United States.
JAMIA Open. 2024 Oct 12;7(4):ooae101. doi: 10.1093/jamiaopen/ooae101. eCollection 2024 Dec.
Understand perceived barriers to and facilitators of using clinical informatics applications for pharmacogenomic (PGx) implementation in resource-limited settings.
We conducted a qualitative research study using a semi-structured interview guide informed by the Consolidated Framework for Implementation Research (CFIR). Interview questions assessed CFIR contextual determinants related to: electronic health record (EHR) infrastructure; clinical informatics personnel and resources; EHR integration of PGx test results; PGx clinical decision support (CDS) tools; institutional resources; and partner receptivity. Transcripts were coded and analyzed to identify themes.
We interviewed 24 clinical informaticists and executive leaders working in rural or underserved health care settings in Montana ( = 15) and Colorado ( = 9) and identified three major themes: (1) EHR infrastructure limitations, (2) insufficient supporting resources, and (3) unique contextual considerations for resource-limited settings. EHR infrastructure limitations included limited agency related to EHR build and interoperability concerns. Theme 1 highlighted challenges associated with integrating structured data into the EHR and inadequate vendor support. Theme 2 included limited familiarity with PGx across the care team, cost concerns, and allocation of non-financial resources. Theme 3 highlighted perceptions about the clinical utility of PGx within rural and underrepresented populations. Potential facilitators, such as being able to act nimbly, were found to coexist among the reported barriers.
Our results provide insight into the clinical informatics infrastructure in resource-limited settings and identify unique considerations for clinical informatics-facilitated PGx implementation. Future efforts in these settings should consider innovative partnerships and strategies to leverage facilitators and minimize barriers associated with integrating PGx CDS applications.
了解在资源有限的环境中,使用临床信息学应用程序实施药物基因组学(PGx)时所感知到的障碍和促进因素。
我们开展了一项定性研究,使用基于实施研究综合框架(CFIR)的半结构化访谈指南。访谈问题评估了与以下方面相关的CFIR背景决定因素:电子健康记录(EHR)基础设施;临床信息学人员和资源;PGx检测结果的EHR整合;PGx临床决策支持(CDS)工具;机构资源;以及合作伙伴的接受度。对访谈记录进行编码和分析以确定主题。
我们采访了在蒙大拿州(n = 15)和科罗拉多州(n = 9)农村或医疗服务不足地区工作的24名临床信息学家和行政领导,并确定了三个主要主题:(1)EHR基础设施限制,(2)支持资源不足,以及(3)资源有限环境的独特背景考虑因素。EHR基础设施限制包括与EHR构建和互操作性问题相关的有限机构。主题1突出了将结构化数据集成到EHR中以及供应商支持不足所带来的挑战。主题2包括整个护理团队对PGx的熟悉程度有限、成本担忧以及非财务资源的分配。主题3突出了对农村和代表性不足人群中PGx临床效用的看法。发现一些潜在的促进因素,如能够灵活行动,与所报告的障碍并存。
我们的结果提供了对资源有限环境中临床信息学基础设施的见解,并确定了临床信息学促进PGx实施的独特考虑因素。在这些环境中的未来努力应考虑创新的伙伴关系和策略,以利用促进因素并尽量减少与整合PGx CDS应用程序相关的障碍。